Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. - Wikidata - wikimedia - TriplyDB

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.

http://www.wikidata.org/entity/Q44346771

about

Chemotherapy for advanced non-small cell lung cancer in the elderly population Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC)Quality of Life in elderly patients with cancer A Novel Strategy to Improve the Therapeutic Efficacy of Gemcitabine for Non-Small Cell Lung Cancer by the Tumor-Penetrating Peptide iRGD Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer.Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.First- and second-line treatment of advanced metastatic non-small-cell lung cancer: a global view.Measurement and impact of co-morbidity in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. A phase II study of weekly paclitaxel.Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity.First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II study Carboplatin and gemcitabine in first-line treatment of elderly patients with advanced non-small cell lung cancer: data from a retrospective study.Evaluation of the efficacy and safety of the combination of gemcitabine and nedaplatin for elderly patients with advanced non-small-cell lung cancer.[A meta analysis of doublets versus single-agent chemotherapy for elderly patients with advanced non-small cell lung cancer].Doublet versus single cytotoxic agent as first-line treatment for elderly patients with advanced non-small-cell lung cancer: a systematic review and meta-analysis.Phase II study of pemetrexed as first-line treatment in elderly (≥75) non-squamous non-small-cell lung cancer: Kyoto Thoracic Oncology Research Group Trial 0901.Doublets versus single-agent therapy as first-line therapy for elderly patients with advanced non-small cell lung cancer? A systematic review of randomised controlled trials.nab-paclitaxel for the management of patients with advanced non-small-cell lung cancer.Pemetrexed versus vinorelbine treatment of advanced non-squamous non-small cell lung cancer in elderly patients Meta-analysis comparing doublet and single cytotoxic agent therapy as first-line treatment in elderly patients with advanced nonsmall-cell lung cancer.Pemetrexed plus carboplatin as adjuvant chemotherapy in patients with curative resected non-squamous non-small cell lung cancer.Treatment of advanced non small cell lung cancer in routine care: a retrospective analysis of 212 consecutive patients treated in a community based oncology group practice The treatment of metastatic non-small cell lung cancer in the elderly: an evidence-based approach Gemcitabine for the treatment of advanced nonsmall cell lung cancer Geriatric oncology: an overview of progresses and challenges.Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Customized chemotherapy based on epidermal growth factor receptor mutation status for elderly patients with advanced non-small-cell lung cancer: a phase II trial.A Phase II study of pulse dose imatinib mesylate and weekly paclitaxel in patients aged 70 and over with advanced non-small cell lung cancer.Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Comparison of platinum-based chemotherapy in patients older and younger than 70 years: an analysis of Southwest Oncology Group Trials 9308 and 9509.Safety and efficacy of vinorelbine in the treatment of non-small cell lung cancer Treating advanced non-small cell lung cancer in the elderly.Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials.Management of elderly patients.Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer.Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)A phase II trial of erlotinib monotherapy for pretreated elderly patients with advanced EGFR wild-type non-small cell lung cancer.Gemcitabine Plus Platinum Combination Chemotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Analysis.Management and geriatric assessment of cancer in the elderly.

P2860

Q24186466-C2579246-B226-4D85-A785-1F35B8F6A273 Q24200518-2B8D4FD2-EC43-4D5C-91F6-92DBD093D8BA Q24243664-76D5542A-EF4D-4281-981E-29AC7B969A9E Q24792196-974A7FAD-FA8E-43AE-AB22-73FC36585E7C Q24802727-63FA3DFB-C4F3-4341-9E14-257042EE3BAE Q28548244-628F8E33-00E1-4D22-86E7-665107CF057A Q33366782-204422D4-3851-4ADD-A979-7A853F891C60 Q33373132-0EBE7ED6-587D-4806-9842-B811CE62778B Q33373493-F5DEE408-A0F8-45FA-8197-FBC88EFA6B7B Q33374962-6CB1D85B-73F3-4921-BEF7-4C97F1C60ED8 Q33375704-1972DE17-4CB0-46AE-AB2D-CB5FD33DBAC9 Q33378383-302DC2D2-B621-469A-9FF9-3858EA309398 Q33396438-07DD6076-887B-4A75-AA3C-BAC4FB35D045 Q33398466-19BCB465-9DDF-457A-AE61-01AB6D66E1FA Q33401712-6A83E208-0972-463B-9921-A584EC90D70A Q33401852-EA5360E8-1B16-47BA-BA00-E68EFDD39C4A Q33406653-9145C55E-F928-4D45-B4E6-EB54848CC3B3 Q33411167-73157986-92F2-44C2-811C-10806B1A247B Q33412928-64185AEC-A1DC-4EDA-86EA-B3F6CBEEC7FF Q33414072-6393B3BF-65B8-43E8-A150-E7EEDE637BB3 Q33426486-29693D17-507C-473C-A222-E60C07CB5A2A Q33429178-5AD5CDEB-A9A9-41B2-83E0-E0EA8A5282A9 Q33860259-EEB604F6-C00F-4E9E-B087-194BAB90FE2D Q33878770-BEADAE57-63C0-4B75-837D-503B7C675DAB Q33915997-174D544C-27EF-4FAC-BCFA-429515CE968C Q33979972-FDA78615-D574-4673-93A5-DCE4F2CDD754 Q34121219-E094C4DB-4D51-4474-9519-A7E6E5EB0A6B Q34276419-EF3967AB-749A-45F7-BDE9-9FA0085FE037 Q34433040-17CC07DB-D814-4328-B5AF-8C94F59A9C4B Q34663877-B5F5293F-DAB9-4126-9AE8-A64EE4187681 Q34786733-16E72B05-F5E9-461B-830E-215A2F033A42 Q35052543-65ECED08-5BB5-4009-8515-21109630EFA0 Q35076283-EED0E0B1-C70C-498F-B668-B5622EF7B0CD Q35111780-5F305E9E-4724-424B-8BDD-EFDEAA2CCEEB Q35200398-B40F005B-4152-4E72-91B7-33B468B16843 Q35536822-409CEB96-9BB3-4657-939E-AB965281894C Q35583866-D0C05C38-59FC-4442-B531-67FDF6DFB4AE Q35653167-CF1D1923-DB81-4A02-AA42-D5DDD0985991 Q35661049-7AD94908-3167-4EBD-8151-F0360523A492 Q35782952-486E2888-EB52-4B8C-8180-ED29BF343AD7

P2860

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.

http://www.wikidata.org/entity/Q44346771

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Chemotherapy for elderly patie ...... S) phase III randomized trial.

@en

Chemotherapy for elderly patie ...... ng Cancer in the Elderly Study

@nl

type

label

Chemotherapy for elderly patie ...... S) phase III randomized trial.

@en

Chemotherapy for elderly patie ...... ng Cancer in the Elderly Study

@nl

prefLabel

Chemotherapy for elderly patie ...... S) phase III randomized trial.

@en

Chemotherapy for elderly patie ...... ng Cancer in the Elderly Study

@nl

P1433

Q44346771-E5FC9D5F-0535-4009-AC12-8F12B0A8566A

P1476

Q44346771-6C695AC6-FEB1-4E03-8C11-A4901DBD95E0

P2093

Q44346771-1590B9CA-9D41-479C-B0F5-1A507E191E27

Q44346771-2475A2D9-74B6-49BB-A424-7C09E6F4F841

Q44346771-42799E22-3DEE-440A-AB6B-04BC9C75AA09

Q44346771-4C640AB9-4114-4C58-8487-33CECDA9C2DC

Q44346771-58DBA4E9-725D-44A5-AA4C-51A8E6EAE197

Q44346771-5AF90536-45F1-47E5-A718-9D511E9F05E8

Q44346771-5CDE51AB-341A-4328-8776-E3FF790FBF91

Q44346771-60AD7AAE-90B3-4C82-AC55-2820166F7C58

Q44346771-613BD7EF-5064-4B6D-A30F-A481C745A59C

Q44346771-6BCC4CF2-907B-4D44-BE38-28E52DBE165C

P2860

Q44346771-0DA33F09-AE3C-44C0-B1E3-A67E8A1769EA

Q44346771-134FC89F-581C-48D0-90C3-3F0A3192D0A7

Q44346771-3B8CF7CC-AC95-4A77-A2BA-8194CD10BB62

Q44346771-551649B9-39E3-4AD6-9FCD-71D1B55BD84D

Q44346771-5D5170E4-CD43-4251-8E8F-BC1ADBE97DFF

Q44346771-74F08714-87FF-4C5E-9710-B635C9E7C89E

Q44346771-84FB0812-903F-4A67-B28A-66AFB7DD4651

Q44346771-9F6AE1B5-DD2A-4877-9273-E31EC8BFC6B0

Q44346771-A54AABE7-06DC-4765-B388-533198B12472

Q44346771-B6B9A405-5C63-48B5-8C24-F310976DBBAE

P304

Q44346771-8EBF0EFE-697C-41B4-9268-D36A8A4DB53B

P31

Q44346771-D09A6813-8CE7-441C-ABAE-FC7552BECE05

P356

Q44346771-54210B1A-31A3-4A35-A8F6-181D56E9939B

P407

Q44346771-6052A2AA-CB20-46E7-8E5C-1CDCEB8A7730

P433

Q44346771-DAC05FBE-6E31-41D3-9D9E-893AF5EDE84B

P478

Q44346771-F8E5DED1-6F75-4CEB-A5D5-04408812BA0C

P50

Q44346771-5548BC1E-CE9D-40C0-B058-263C3AAF453B

P577

Q44346771-CB88861E-1969-4D18-9172-41E217863094

P5875

Q44346771-5DE09FB2-ADB0-4F71-B1C4-6FF21032962E

P698

Q44346771-0AF6B32B-5482-461E-9271-156058D07D98

P921

Q44346771-0B1E50DD-763E-4BED-801A-A70026888B4D

Q44346771-0EB8BAB3-225F-424E-944F-B5CE26B94640

Q44346771-C4E1EAD3-AAB3-4C85-A4B5-C9E102522CDF

Q44346771-E67E4835-559F-49F2-B9AF-073E4BC5C6EB

P356

P1433

Journal of the National Cancer Institute

P1476

Chemotherapy for elderly patie ...... S) phase III randomized trial.

@en

P2093

Adolfo Favaretto

http://www.w3.org/2001/XMLSchema#string

Antonio Rossi

http://www.w3.org/2001/XMLSchema#string

Ciro Gallo

http://www.w3.org/2001/XMLSchema#string

Cosimo Sacco

http://www.w3.org/2001/XMLSchema#string

Domenico Galetta

http://www.w3.org/2001/XMLSchema#string

Elena Piazza

http://www.w3.org/2001/XMLSchema#string

Federico Castiglione

http://www.w3.org/2001/XMLSchema#string

Francesco Ferraù

http://www.w3.org/2001/XMLSchema#string

Francesco Perrone

http://www.w3.org/2001/XMLSchema#string

Francesco Rosetti

http://www.w3.org/2001/XMLSchema#string

P2860

A multiple testing procedure for clinical trials

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

Reporting results of cancer treatment

Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial.

Age and the treatment of lung cancer.

Geriatric oncology: challenges for the new century.

Global cancer statistics in the year 2000.

Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses. Gem Vin Investigators.

Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living.

Testing whether an identified treatment is best.

P304

362-372

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/95.5.362

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

Cesare Gridelli

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10871437

http://www.w3.org/2001/XMLSchema#string

P698

12618501

http://www.w3.org/2001/XMLSchema#string

P921

phase III clinical trial